期刊文献+

Transwell侵袭实验测定M受体对胆管癌细胞侵袭的影响 被引量:7

The evaluation of the muscarinicreceptor on the in vitro invasion of the human cholangiocarcinoma cells with Transwell chamber assay
原文传递
导出
摘要 目的 探讨Transwell体外侵袭模型适用于胆管癌侵袭性研究的实验条件和方法.观察M受体兴奋剂及拈抗剂对胆管癌侵袭力的影响.方法 将不同浓度(0.5×10^5/mL、1.0×10^5/mL、1.5×10^5/mL、2.0×10^5/mL)的胆管癌细胞200μL置入Transwell小室侵袭模型,分别培养12 h、24 h、36 h、48 h,观察不同浓度细胞在不同时间穿透基质凝胶多空滤膜的细胞数.选取最适浓度的胆管癌细胞与匹罗卡品共同加入 Transwell 的上室,调整小室内匹罗卡品浓度分别为0 mmol/L、0.1 mmol/L、0.3mmol/L、0.5mmol/L,培养最适时间后染色计数小室膜上的细胞数。调整浓度分别为0.01mmol/L、0.01mmol/L、0.05mmol/L、0.1mmol/L的阿托品对应匹罗卡品浓度分别为0、0.3mmoL/L、0.3rrmaol/L、0.3mmol/L与胆管癌细胞共同加入Transwell小室培养后染色计数。结果随着作用时间及细胞浓度的增加,穿透基质胶的细胞数随之增多,但当时间超过36h,细胞浓度大于1.0×10^5/mL时增长趋于平稳。加入匹罗卡品后,对照组与实验组比较差异有统计学意义(P〈0.05),实验组高中低浓度之间的差异无统计学意义。单阿托品组与空白对照组比较差异无统计学意义(P〉0.05)。加入匹罗卡品及阿托品后,单阿托品组与实验组比较,差异有统计学意义(P〈0.05),低中高浓度组之间差异无统计学意义。结论36h的侵袭时间和1.0×10^5/mL的细胞浓度最能体现不同药物或试剂对胆管癌细胞的侵袭能力的影响,而受细胞浓度和侵袭时间的影响较小。胆管癌细胞可能存在M受体,并且在胆管癌的浸润和转移中具有重要作用。 Objective To explore the experiment condition and method for the application of in vitro in vasive Transwell chamber and to observe muscarinicreceptor stimulant and muscarinicreceptor antagonist's influence to cholangiocarcinoma's invasiveness.Methods Two hundred microliter cell suspension of various concentrations(0.5×10^5/mL,1.0×10^5/mL,1.5×10^5/mL and 2.0×10^5/mL)was added into the upper chamber of the Transwell chamber,and the cells were allowed to penetrate the matrigel for 12,18,24and 48 hours respectively.The numbers was gotten as the invasive cells on the under surface of the membrane.After optimal cell concentration and time were gotten,pilocarpine of various concentrations(0 mmol/L,0.1 mmol/L,0.3 mmol/L and 0.5 mmoL/L)was added into the upper chamber of the Transwell chamber,then the cells on the matrigel were stained and counted.So did the cells when atropine of various concentrations(0.01 mmol/L,0.01 mmol/L,0.05 mmoVL and 0.1 mmol/L)were added into the upper chamher of the Transwell chamber in according to pilocarpine of various concentrations(0 mmol/L,0.3 mmol/L,0.3 mmol/L and 0.3mmol/L).Results With the increase of the time and cell concentrations,the cells couts that penetrated the matrigel increased,while the increase tended to he stable when the culture time exceeded 36 hous and the cell concentration Was over 1.0×10^5/mL.By adding pilocarpine,there were significant differences between the control and experimental groups(P〈0.05),but there were no significant differences in experimental groups with various concentrations.There were no significant differences in blank group and experimental groups with atropine added(P〉0.05).When added pilocarpine and atropine,there were significant differences between blank and experimental groups(P〈0.05),but there were no significant differences in experimental groups with various concentrations.Conclusions Thirty-six hours as invasive time,and one cell concentration 1.0 × 10^5/mL were optimal to test invasion abilities
出处 《国际外科学杂志》 2011年第5期298-301,F0003,共5页 International Journal of Surgery
关键词 Transwell小室 胆管癌 M受体 体外侵袭 Transwell chamber Cholangiocarcinoma Muscarinicreceptor In vitro invasiveness
  • 相关文献

参考文献6

二级参考文献57

共引文献21

同被引文献56

  • 1Yu-Jie Feng,Bing-Yuan Zhang,Ru-Yong Yao and Yun LuSecond Department of General Surgery and Central Laboratory of Molecular Biology,Affiliated Medical College Hospital,Qingdao University,Qingdao 266003,China.Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells[J].Hepatobiliary & Pancreatic Diseases International,2012,11(4):418-423. 被引量:4
  • 2邵月婷,高丽芳,孙连坤,赵丹,计国义,胡嘉弟,李扬,赵雪俭.ATRA联合IFN-α对PC-3细胞株的生长抑制作用以及对GRIM-19和STAT3基因表达的影响[J].肿瘤,2006,26(3):228-231. 被引量:7
  • 3汤钊猷.转移复发-肝癌研究的重中之重[J].中华消化外科杂志,2007,6(1):2-2. 被引量:12
  • 4Qin S, Bai Y, Lim HY, et al. Randomized, multicenter, open- label study of oxaliplatin plus fluorouracil/leucovorin versus doxo- rubicin as palliative chemotherapy in patients with advanced hep- atocellular carcinoma from asia [ J]. J Clin Oncol, 2013, 31 (28) : 3501- 3508. 被引量:1
  • 5Rupnow BAr Murtha AD, Alarcon RM, et al. Direct evidence that apoptosis enhances tumor responses to fractionated radiother- apy[ J]. Cancer Res, 1998, 58(9) : 1779-1784. 被引量:1
  • 6Liu L, Cao Y, ChenC, et al. Sorafenib blocks the RAF/MEK/ ERK pathway, inhibits tumor angiogenesis, and induces tumor celi apoptosis in hepatocellular carcinoma model PLC/PRF/5 [J]. Cancer Res, 2006, 66(24) : 11851-11858. 被引量:1
  • 7Richly H, Henning BF, Kupsch P, et al. Results of a Phase I trial of sorafenib (BAY 43-9006 ) in combination with doxorubicin in patients with refractory solid tumors[ J]. Ann On- col, 2006, 17(5) :866-873. 被引量:1
  • 8Richly H, Schultheis B, Adamietz IA, et al. Combination of sor- afenib and doxorubicin in patients with advanced hepatocellular carcinoma : results from a phase I extension trial [ J ]. Eur J Canc- er, 2009, 45(4) : 579-587. 被引量:1
  • 9Yen Y, Lim DW, Chung V, et al. Phase 1I study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocel- lular cancer: a California Cancer Consortium triM[ J]. Am J Clin Oncol, 2008, 31(4): 317-322. 被引量:1
  • 10崔彦芝,陈逢生,罗荣城,李爱民,伍婧,张华.索拉非尼联合顺铂抑制肝癌HepG2细胞生长的体外研究[J].解放军医学杂志,2008,33(4):397-399. 被引量:12

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部